drugset / Trial / NCT05444439

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

NCT05444439

Completed 100 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

* Detection of primary antimicrobial susceptibility and resistance of Helicobacter Pylori infection. * Detection of resistance and virulence genes of Helicobacter Pylori infection. * Assessment of H pylori carcinogenicity gene. * Evaluation of outcome and efficacy of antibiotics regimen will be used in our research. * Evaluation of effect of other factors as diet (fatty and spicy meal), drugs as NSAIDs use, antibiotics for any cause on response of H pylori to antibiotics regimen.

Timeline

Start
2024-01-20
Primary completion
2024-09-15
Completion
2025-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg
Subject Levofloxacin Small molecule 400 mg